bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012
|
|
|
- Lily Matthews
- 6 years ago
- Views:
Transcription
1 bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012
2 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
3 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
4 BCL BioChemistry Library C++ library for small molecule and protein modeling Machine learning techniques OpenCL GPU-Acceleration
5 bcl::cheminfo Goal MYSQL GPU HPC Automation
6 bcl::cheminfo Goal MYSQL GPU HPC Automation
7 Machine Learning Calculates Properties from Numerical Description Chemical Structure a) b) c) d) e) f) I(s) s Predicted Value 7
8 Encoding Chemical Data Scalar Descriptors 2D/3D Autocorrelation Weight H-Bond donor H-Bond acceptor, Topological polar surface area (TPSA) Radial Distribution Function vdwaals Surface Area 60 descriptor groups 1284 numerical descriptor values
9 RDF identity Radial Distribution Functions Describe 3D Shape Å 3.26 Å Å 5 0 d / Å ǁ where: d ij distance between two atoms B temperature factor, here 100
10 RDF partial charge but can also Encode Chemical Properties such as Partial Charge Å 3.26 Å Å 5 0 d / Å ǁ where: d ij distance between two atoms A i, A j atom properties, here lone pair electro negativity B temperature factor, here 100
11 Machine Learning Calculates Properties from Numerical Description Chemical Structure a) b) c) d) e) f) I(s) s Predicted Value 11
12 Protocol For Model Training 10% independent 10% monitoring 80% training Feature forward descriptor selection 5-fold cross-validated models consensus prediction
13 Forward Feature Selection cv * n n+1 2 = 9150
14 GPU Performance Data Set ID Actives Inactives 884 3,438 7, ,398 65, ,897 ML Method ANN 109/1 (109) 1151/10 (115) 3660/32 (114) SVM 14/0.4 (35) 145/5 (29) 441/14 (32) KNN 7/0.4 (18) 714/25 (29) 6118/90 (68)
15 GPU Performance Data Set ID Actives Inactives 884 3,438 7, ,398 65, ,897 Similarity Measure Tanimoto 53/0.2 (265) 147/0.55 (267) 3.4/0.02 (170) Cosine 47/0.2 (235) 150/0.53 (283) 3.5/0.02 (175) Dice 52/0.2 (260) 145/0.54 (269) 3.9/0.02 (195) Euclidean 27/0.2 (138) 95/0.51 (186) 2.3/0.01 (230) Manhattan 20/0.2 (100) 56/0.52 (108) 1.6/0.01 (160)
16 bcl::cheminfo Suite Molecule -> feature vectors (descriptors) Feature Selection (FFS, BFS, ISA, PCA*; PBS) Diverse objective functions ANN*, SVR*, knn*, Kohonen, DT MYSQL Model analysis Virtual Screening Similarity Analysis* Note: * = GPU-accelerated Lowe Jr, E.W., et al. GPU-Accelerated Machine Learning Techniques Enable QSAR Modeling of Large HTS Data. in Symposium on Computational Intelligence in Bioinformatics and Computational Biology San Diego, CA: IEEE.
17 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
18 logp Prediction Metric of hydrophobicity Important for molecule fate Logarithm of the octanol-water partition coefficient 22,500 compounds from MDDR, reaxys, SciFinder
19 SVM predicted LogP values XlogP predicted LogP values KNN predicted LogP values ANN predicted LogP Values logp Prediction experimental LogP values experimental LogP values knn SVM ANN XLogP experimental LogP values Experimental LogP values
20 Consensus prediction of ANN, SVM, and k-nn ANN+SVM+KNN experimental LogP values Lowe, E.W., Jr., et al., Comparative Analysis of Machine Learning Techniques for the Prediction of LogP, in SSCI 2011 CIBCB Symposium on Computational Intelligence in Bioinformatics and Computational Biology2011: Paris, France
21 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
22 High-Throughput Screen yields 1387 PAMs and 345 NAMs of mglur 5 150,000 compounds were tested for allosteric modulation of mglur 5 1,387 (0.94%) compounds were verified as PAMs of mglur (0.23%) compounds were verified as NAMs of mglur 5. Niswender, C. M.; Johnson, K. A.; Luo, Q.; Ayala, J. E.; Kim, C.; Conn, P. J.; Weaver, C. D. Mol Pharmacol 2008, 73,
23 True Positives (%) Virtual Screen for Highly Active Compounds and Novel Leads vhts Training Optimization (ROC curves) A) True positive B) False negative C) False positive D) True negative False Positives (%) Enrichment of Active Compounds by 43x Enrichment = TP P TP + FP P + N
24 Experimental Results mglur 5 Positive Allosteric Modulators ~450,000 ChemBridge 824 Compounds predicted with EC 50 < 1μM by QSAR model 232 Compounds (28.1%) were confirmed as mglur 5 PAMs Enrichment = 28.1% / 0.96% = 30 Mueller, R., et al., Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS Chemical Neuroscience, (4): p
25 Experimental Results mglur 5 Negative Allosteric Modulators ~750,000 ChemBridge 749 Compounds with novel Scaffolds predicted with EC 50 < 10μM by QSAR model 12 Compounds (3.6%) were confirmed as mglur 5 NAMs Enrichment = 3.6% / 0.23% = 16 VU EC 50 = 75 nm HET HET VU EC 50 = 124 nm HET HET Ar CN Ar COOEt Mueller, R., et al., Discovery of 2-(2-Benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mglu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound. ChemMedChem, (3): p
26 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
27 CYP 3A4 Metabolism of xenobiotics Oxidizes largest range of substrates of all CYPs Present in largest quantity in liver Involved in metabolism of ½ of the drugs used today Activates many toxins 3,438 actives 7,066 inactive
28 CYP3A4 Model Performance Method Average Enrichment Number Features ANN SVM KNN Kohonen DT ANN/KNN/ Kohonen 2.89 * Enrichment = TP P TP + FP P + N
29 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
30 Malaria parasitic disease high fevers, flu-like symptoms, anemia 250 million cases of fever and ~1 million deaths annually Malaria risk Malaria free Parasite digests hemoglobin free heme toxic to host cells parasite crystallizes heme to hemozoin hemozoin crystallization target of Malaria therapeutics
31 Malaria Model Optimization Workflow ~134,000 compounds screened for inhibition of hemozoin crystallization 1,314 inhibitors were found Train consensus QSAR model 134K compounds 1314 Hits Acquire predicted hits (vendor) Virtually screen GSK library
32 Malaria Model Performance Quality Measures: Integral under ROC Curve RMSD Enrichments for different cutoffs: Cutoff (False Positive Rate) Enrichment top 1% 33.2 top 2% 27.1 top 5% 19.0
33 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP 3A4 Malaria KRas
34 KRas GTPase Indicated in Cancer Leukemia Colon Pancreatic Lung
35 KRas NMR Fragment Screen ~10k fragments screened hits with K d s = 242 Virtual screen of PubChem and Chembridge (~40m) Rank-list top 2500
36 Acknowledgments Nils Woetzel Mariusz Butkiewicz Ralf Mueller Matthew Spellings Albert Omlor Zollie White Jens Meiler Collaborators Conn Wright Fesik Funding NIH 5T90DA (Integrative Training in Therapeutic Discovery; PI: Marnett) NIH 1R21MH and 1R01MH (NIMH; PI: Meiler) NSF OCI (Transformative Computational Science using CyberInfrastructure; PI: Lowe)
Comparative Analysis of Machine Learning Techniques for the Prediction of LogP
Comparative Analysis of Machine Learning Techniques for the Prediction of LogP Edward W. Lowe, Jr., Mariusz Butkiewicz, Matthew Spellings, Albert Omlor, Jens Meiler Abstract Several machine learning techniques
GPU-Accelerated Machine Learning Techniques Enable QSAR Modeling Of Large HTS Data
GPU-Accelerated Machine Learning Techniques Enable QSAR Modeling Of Large HTS Data Edward W. Lowe, Jr., Mariusz Butkiewicz, Nils Woetzel, Jens Meiler Abstract Quantitative structure activity relationship
Comparative Analysis of Machine Learning Techniques for the Prediction of the DMPK Parameters Intrinsic Clearance and Plasma Protein Binding
Comparative Analysis of Machine Learning Techniques for the Prediction of the DMPK Parameters Intrinsic Clearance and Plasma Protein Binding Edward W. Lowe, Jr., Mariusz Butkiewicz, Zollie White III, Matthew
Introduction to Chemoinformatics and Drug Discovery
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.
Bcl::ChemInfo - Qualitative Analysis Of Machine Learning Models For Activation Of HSD Involved In Alzheimer s Disease
Bcl::ChemInfo - Qualitative Analysis Of Machine Learning Models For Activation Of HSD Involved In Alzheimer s Disease Mariusz Butkiewicz, Edward W. Lowe, Jr., Jens Meiler Abstract In this case study, a
Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.
Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of
MACHINE LEARNING ALGORITHMS FOR PREDICTION OF BIOLOGICAL ACTIVITY AND CHEMICAL PROPERTIES. Ralf Mueller. Dissertation. Submitted to the Faculty of the
MACHINE LEARNING ALGORITHMS FOR PREDICTION OF BIOLOGICAL ACTIVITY AND CHEMICAL PROPERTIES By Ralf Mueller Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial
In silico pharmacology for drug discovery
In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of
Structure-Activity Modeling - QSAR. Uwe Koch
Structure-Activity Modeling - QSAR Uwe Koch QSAR Assumption: QSAR attempts to quantify the relationship between activity and molecular strcucture by correlating descriptors with properties Biological activity
Machine Learning Concepts in Chemoinformatics
Machine Learning Concepts in Chemoinformatics Martin Vogt B-IT Life Science Informatics Rheinische Friedrich-Wilhelms-Universität Bonn BigChem Winter School 2017 25. October Data Mining in Chemoinformatics
QSAR Modeling of Human Liver Microsomal Stability Alexey Zakharov
QSAR Modeling of Human Liver Microsomal Stability Alexey Zakharov CADD Group Chemical Biology Laboratory Frederick National Laboratory for Cancer Research National Cancer Institute, National Institutes
De Novo molecular design with Deep Reinforcement Learning
De Novo molecular design with Deep Reinforcement Learning @olexandr Olexandr Isayev, Ph.D. University of North Carolina at Chapel Hill olexandr@unc.edu http://olexandrisayev.com About me Ph.D. in Chemistry
Structural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
Development and application of ligand-based computational methods for de-novo drug. design and virtual screening. Alexander Richard Geanes.
Development and application of ligand-based computational methods for de-novo drug design and virtual screening By Alexander Richard Geanes Thesis Submitted to the Faculty of the Graduate School of Vanderbilt
Drug Informatics for Chemical Genomics...
Drug Informatics for Chemical Genomics... An Overview First Annual ChemGen IGERT Retreat Sept 2005 Drug Informatics for Chemical Genomics... p. Topics ChemGen Informatics The ChemMine Project Library Comparison
Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs
Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs William (Bill) Welsh welshwj@umdnj.edu Prospective Funding by DTRA/JSTO-CBD CBIS Conference 1 A State-wide, Regional and National
MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.
Module Structure: (15 credits each) Lectures and Assessment: 50% coursework, 50% unseen examination. Module Title Module 1: Bioinformatics and structural biology as applied to drug design MEDC0075 In the
Virtual screening in drug discovery
Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery
Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME
Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells
Plan. Day 2: Exercise on MHC molecules.
Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:
Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
Using AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
Advanced Medicinal Chemistry SLIDES B
Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability
Early Stages of Drug Discovery in the Pharmaceutical Industry
Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery
Introduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
Chemical library design
Chemical library design Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery Today,
Cheminformatics analysis and learning in a data pipelining environment
Molecular Diversity (2006) 10: 283 299 DOI: 10.1007/s11030-006-9041-5 c Springer 2006 Review Cheminformatics analysis and learning in a data pipelining environment Moises Hassan 1,, Robert D. Brown 1,
Receptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
Iterative experimental and virtual high-throughput screening identifies metabotropic glutamate receptor subtype 4 positive allosteric modulators
DOI 10.1007/s00894-012-1441-0 ORIGINAL PAPER Iterative experimental and virtual high-throughput screening identifies metabotropic glutamate receptor subtype 4 positive allosteric modulators Ralf Mueller
Machine learning for ligand-based virtual screening and chemogenomics!
Machine learning for ligand-based virtual screening and chemogenomics! Jean-Philippe Vert Institut Curie - INSERM U900 - Mines ParisTech In silico discovery of molecular probes and drug-like compounds:
Contents 1 Open-Source Tools, Techniques, and Data in Chemoinformatics
Contents 1 Open-Source Tools, Techniques, and Data in Chemoinformatics... 1 1.1 Chemoinformatics... 2 1.1.1 Open-Source Tools... 2 1.1.2 Introduction to Programming Languages... 3 1.2 Chemical Structure
est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today
est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today Sign up for FREE GPU Test Drive on remotely hosted clusters www.nvidia.com/gputestd rive Shape Searching
Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw
Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery
21 th /June/2018@CUGM Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery Kaz Ikeda, Ph.D. Keio University Self Introduction Keio University, Tokyo, Japan (Established
Similarity methods for ligandbased virtual screening
Similarity methods for ligandbased virtual screening Peter Willett, University of Sheffield Computers in Scientific Discovery 5, 22 nd July 2010 Overview Molecular similarity and its use in virtual screening
Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015
Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies
Topology based deep learning for biomolecular data
Topology based deep learning for biomolecular data Guowei Wei Departments of Mathematics Michigan State University http://www.math.msu.edu/~wei American Institute of Mathematics July 23-28, 2017 Grant
Data Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
has its own advantages and drawbacks, depending on the questions facing the drug discovery.
2013 First International Conference on Artificial Intelligence, Modelling & Simulation Comparison of Similarity Coefficients for Chemical Database Retrieval Mukhsin Syuib School of Information Technology
Bridging the Dimensions:
Bridging the Dimensions: Seamless Integration of 3D Structure-based Design and 2D Structure-activity Relationships to Guide Medicinal Chemistry ACS Spring National Meeting. COMP, March 13 th 2016 Marcus
Introduction to Chemoinformatics
Introduction to Chemoinformatics Dr. Igor V. Tetko Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH) Institute of Bioinformatics & Systems Biology (HMGU) Kyiv, 10 August
Data Mining in the Chemical Industry. Overview of presentation
Data Mining in the Chemical Industry Glenn J. Myatt, Ph.D. Partner, Myatt & Johnson, Inc. glenn.myatt@gmail.com verview of presentation verview of the chemical industry Example of the pharmaceutical industry
Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
October 6 University Faculty of pharmacy Computer Aided Drug Design Unit
October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes
CHEMINFORMATICS MODELING OF DIVERSE AND DISPARATE BIOLOGICAL DATA AND THE USE OF MODELS TO DISCOVER NOVEL BIOACTIVE MOLECULES
CHEMINFORMATICS MODELING OF DIVERSE AND DISPARATE BIOLOGICAL DATA AND THE USE OF MODELS TO DISCOVER NOVEL BIOACTIVE MOLECULES Man Luo A dissertation submitted to the faculty of the University of North
Molecular Complexity Effects and Fingerprint-Based Similarity Search Strategies
Molecular Complexity Effects and Fingerprint-Based Similarity Search Strategies Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-aturwissenschaftlichen Fakultät der Rheinischen
BUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions
BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted
QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression
APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor
ADMET property estimation, oral bioavailability predictions, SAR elucidation, & QSAR model building software www.simulations-plus.com +1-661-723-7723 What is? is an advanced computer program that enables
Hit Finding and Optimization Using BLAZE & FORGE
Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology
Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller
Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics
Applications of multi-class machine
Applications of multi-class machine learning models to drug design Marvin Waldman, Michael Lawless, Pankaj R. Daga, Robert D. Clark Simulations Plus, Inc. Lancaster CA, USA Overview Applications of multi-class
QSAR in Green Chemistry
QSAR in Green Chemistry Activity Relationship QSAR is the acronym for Quantitative Structure-Activity Relationship Chemistry is based on the premise that similar chemicals will behave similarly The behavior/activity
Cross Discipline Analysis made possible with Data Pipelining. J.R. Tozer SciTegic
Cross Discipline Analysis made possible with Data Pipelining J.R. Tozer SciTegic System Genesis Pipelining tool created to automate data processing in cheminformatics Modular system built with generic
TRAINING REAXYS MEDICINAL CHEMISTRY
TRAINING REAXYS MEDICINAL CHEMISTRY 1 SITUATION: DRUG DISCOVERY Knowledge survey Therapeutic target Known ligands Generate chemistry ideas Chemistry Check chemical feasibility ELN DBs In-house Analyze
Biologically Relevant Molecular Comparisons. Mark Mackey
Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist
Kernel-based Machine Learning for Virtual Screening
Kernel-based Machine Learning for Virtual Screening Dipl.-Inf. Matthias Rupp Beilstein Endowed Chair for Chemoinformatics Johann Wolfgang Goethe-University Frankfurt am Main, Germany 2008-04-11, Helmholtz
Kinome-wide Activity Models from Diverse High-Quality Datasets
Kinome-wide Activity Models from Diverse High-Quality Datasets Stephan C. Schürer*,1 and Steven M. Muskal 2 1 Department of Molecular and Cellular Pharmacology, Miller School of Medicine and Center for
Development of QSAR Models for Identification of CYP3A4 Substrates and Inhibitors
Mol2Net, 2015, 1(Section B), pages 1-6, Proceedings 1 SciForum Mol2Net Development of QSAR Models for Identification of CYP3A4 Substrates and Inhibitors Flavia C. Silva, Ekaterina V. Varlamova, Rodolpho
FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )
FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC ) SARomics Biostructures AB & Red Glead Discovery AB Medicon Village, Lund, Sweden Fragment-based lead discovery The basic idea:
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,
Principles of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS
EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS PETER GUND Pharmacopeia Inc., CN 5350 Princeton, NJ 08543, USA pgund@pharmacop.com Empirical and theoretical approaches to drug discovery have often
Exploring the black box: structural and functional interpretation of QSAR models.
EMBL-EBI Industry workshop: In Silico ADMET prediction 4-5 December 2014, Hinxton, UK Exploring the black box: structural and functional interpretation of QSAR models. (Automatic exploration of datasets
Structure-based maximal affinity model predicts small-molecule druggability
Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results
Computational Biology 1
Computational Biology 1 Protein Function & nzyme inetics Guna Rajagopal, Bioinformatics Institute, guna@bii.a-star.edu.sg References : Molecular Biology of the Cell, 4 th d. Alberts et. al. Pg. 129 190
FRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of
Xia Ning,*, Huzefa Rangwala, and George Karypis
J. Chem. Inf. Model. XXXX, xxx, 000 A Multi-Assay-Based Structure-Activity Relationship Models: Improving Structure-Activity Relationship Models by Incorporating Activity Information from Related Targets
Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland
Navigation in Chemical Space Towards Biological Activity Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland Data Explosion in Chemistry CAS 65 million molecules CCDC 600 000 structures
Computational Methods and Drug-Likeness. Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004
Computational Methods and Drug-Likeness Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004 The Problem Drug development in pharmaceutical industry: >8-12 years time ~$800m costs >90% failure
Computational chemical biology to address non-traditional drug targets. John Karanicolas
Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints
An Integrated Approach to in-silico
An Integrated Approach to in-silico Screening Joseph L. Durant Jr., Douglas. R. Henry, Maurizio Bronzetti, and David. A. Evans MDL Information Systems, Inc. 14600 Catalina St., San Leandro, CA 94577 Goals
Virtual Screening: How Are We Doing?
Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global
LIBRARY DESIGN FOR COLLABORATIVE DRUG DISCOVERY: EXPANDING DRUGGABLE CHEMOGENOMIC SPACE
5 th /June/2018@British Embassy in Tokyo LIBRARY DESIGN FOR COLLABORATIVE DRUG DISCOVERY: EXPANDING DRUGGABLE CHEMOGENOMIC SPACE Kazuyoshi Ikeda, Ph.D. Keio University SELF-INTRODUCTION Keio University,
Important Aspects of Fragment Screening Collection Design
Important Aspects of Fragment Screening Collection Design Phil Cox, Ph. D., Discovery Chemistry and Technology, AbbVie, USA Cresset User Group Meeting, Cambridge UK. Thursday, June 29 th 2017 Disclosure-
Structural interpretation of QSAR models a universal approach
Methods and Applications of Computational Chemistry - 5 Kharkiv, Ukraine, 1 5 July 2013 Structural interpretation of QSAR models a universal approach Victor Kuz min, Pavel Polishchuk, Anatoly Artemenko,
A COMPARATIVE STUDY OF MACHINE-LEARNING-BASED SCORING FUNCTIONS IN PREDICTING PROTEIN-LIGAND BINDING AFFINITY. Hossam Mohamed Farg Ashtawy A THESIS
A COMPARATIVE STUDY OF MACHINE-LEARNING-BASED SCORING FUNCTIONS IN PREDICTING PROTEIN-LIGAND BINDING AFFINITY By Hossam Mohamed Farg Ashtawy A THESIS Submitted to Michigan State University in partial fulfillment
Prediction and Classif ication of Human G-protein Coupled Receptors Based on Support Vector Machines
Article Prediction and Classif ication of Human G-protein Coupled Receptors Based on Support Vector Machines Yun-Fei Wang, Huan Chen, and Yan-Hong Zhou* Hubei Bioinformatics and Molecular Imaging Key Laboratory,
Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
Development of a Structure Generator to Explore Target Areas on Chemical Space
Development of a Structure Generator to Explore Target Areas on Chemical Space Kimito Funatsu Department of Chemical System Engineering, This materials will be published on Molecular Informatics Drug Development
Classification of Highly Unbalanced CYP450 Data of Drugs Using Cost Sensitive Machine Learning Techniques
92 J. Chem. Inf. Model. 2007, 47, 92-103 Classification of Highly Unbalanced CYP450 Data of Drugs Using Cost Sensitive Machine Learning Techniques T. Eitrich, A. Kless,*, C. Druska, W. Meyer, and J. Grotendorst
ESPRESSO (Extremely Speedy PRE-Screening method with Segmented compounds) 1
Vol.2016-MPS-108 o.18 Vol.2016-BI-46 o.18 ESPRESS 1,4,a) 2,4 2,4 1,3 1,3,4 1,3,4 - ESPRESS (Extremely Speedy PRE-Screening method with Segmented cmpounds) 1 Glide HTVS ESPRESS 2,900 200 ESPRESS: An ultrafast
QSAR/QSPR modeling. Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships
Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships QSAR/QSPR modeling Alexandre Varnek Faculté de Chimie, ULP, Strasbourg, FRANCE QSAR/QSPR models Development Validation
György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
Enamine Golden Fragment Library
Enamine Golden Fragment Library 14 March 216 1794 compounds deliverable as entire set or as selected items. Fragment Based Drug Discovery (FBDD) [1,2] demonstrates remarkable results: more than 3 compounds
Solved and Unsolved Problems in Chemoinformatics
Solved and Unsolved Problems in Chemoinformatics Johann Gasteiger Computer-Chemie-Centrum University of Erlangen-Nürnberg D-91052 Erlangen, Germany Johann.Gasteiger@fau.de Overview objectives of lecture
Similarity Search. Uwe Koch
Similarity Search Uwe Koch Similarity Search The similar property principle: strurally similar molecules tend to have similar properties. However, structure property discontinuities occur frequently. Relevance
The reuse of structural data for fragment binding site prediction
The reuse of structural data for fragment binding site prediction Richard Hall 1 Motivation many examples of fragments binding in a phenyl shaped pocket or a kinase slot good shape complementarity between
Translating Methods from Pharma to Flavours & Fragrances
Translating Methods from Pharma to Flavours & Fragrances CINF 27: ACS National Meeting, New Orleans, LA - 18 th March 2018 Peter Hunt, Edmund Champness, Nicholas Foster, Tamsin Mansley & Matthew Segall
A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery
AtomNet A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery Izhar Wallach, Michael Dzamba, Abraham Heifets Victor Storchan, Institute for Computational and
1. Some examples of coping with Molecular informatics data legacy data (accuracy)
Molecular Informatics Tools for Data Analysis and Discovery 1. Some examples of coping with Molecular informatics data legacy data (accuracy) 2. Database searching using a similarity approach fingerprints
MM-PBSA Validation Study. Trent E. Balius Department of Applied Mathematics and Statistics AMS
MM-PBSA Validation Study Trent. Balius Department of Applied Mathematics and Statistics AMS 535 11-26-2008 Overview MM-PBSA Introduction MD ensembles one snap-shots relaxed structures nrichment Computational
Protein structure based approaches to inhibit Plasmodium DHODH for malaria
Protein structure based approaches to inhibit Plasmodium DHDH for malaria Peter Johnson University of Leeds, School of Chemistry email p.johnson@leeds.ac.uk Tools for protein structure based approaches
Interactive Feature Selection with
Chapter 6 Interactive Feature Selection with TotalBoost g ν We saw in the experimental section that the generalization performance of the corrective and totally corrective boosting algorithms is comparable.
Quantitative structure activity relationship and drug design: A Review
International Journal of Research in Biosciences Vol. 5 Issue 4, pp. (1-5), October 2016 Available online at http://www.ijrbs.in ISSN 2319-2844 Research Paper Quantitative structure activity relationship
Chemical Space: Modeling Exploration & Understanding
verview Chemical Space: Modeling Exploration & Understanding Rajarshi Guha School of Informatics Indiana University 16 th August, 2006 utline verview 1 verview 2 3 CDK R utline verview 1 verview 2 3 CDK
Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters
Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)
A mapping based on physico-chemical features: lessons learned
A mapping based on physico-chemical features: lessons learned Ann DETROYER, PhD L Oréal Research and Innovation, Aulnay, France EPA (ToxCast ) - L Oréal Partners to develop high throughput and non animal
A reliable computational workflow for the selection of optimal screening libraries
DOI 10.1186/s13321-015-0108-0 RESEARCH ARTICLE Open Access A reliable computational workflow for the selection of optimal screening libraries Yocheved Gilad 1, Katalin Nadassy 2 and Hanoch Senderowitz